Endometrial hyperplasia ultrasound: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Pelvic ultrasound on days 5 to 10 of menstrual cycle reduce the variability in endometrial thickness and may be helpful in the diagnosis of endometrial hyperplasia. On pelvic ultrasound, endometrial hyperplasia is characterized by a homogeneous increase in the endometrial thickness in the majority of patients. However, endometrial hyperplasia may also cause asymmetric or focal thickening with surface irregularity which should raise a suspicion for | Pelvic ultrasound on days 5 to 10 of [[menstrual cycle]] reduce the variability in endometrial thickness and may be helpful in the diagnosis of endometrial hyperplasia. On pelvic [[ultrasound]], endometrial hyperplasia is characterized by a homogeneous increase in the endometrial thickness in the majority of patients. However, endometrial hyperplasia may also cause asymmetric or focal thickening with surface irregularity which should raise a suspicion for [[malignancy]].<ref name=qw>Endometrial hyperplasia. Radiopedia. http://radiopaedia.org/articles/endometrial-hyperplasia-1 Accessed on March 10, 2016.</ref> | ||
==Ultrasound== | ==Ultrasound== | ||
*Pelvic ultrasound on days 5 to 10 of menstrual cycle reduce the variability in endometrial thickness and may be helpful in the diagnosis of endometrial hyperplasia. | *Pelvic [[ultrasound]] on days 5 to 10 of [[menstrual cycle]] reduce the variability in endometrial thickness and may be helpful in the diagnosis of endometrial hyperplasia. | ||
*The ultrasound appearance can be non-specific and may not be reliable to differentiate between hyperplasia and carcinoma.<ref name="pmid12130438">{{cite journal| author=Jorizzo JR, Chen MY, Martin D, Dyer RB, Weber TM| title=Spectrum of endometrial hyperplasia and its mimics on saline hysterosonography. | journal=AJR Am J Roentgenol | year= 2002 | volume= 179 | issue= 2 | pages= 385-9 | pmid=12130438 | doi=10.2214/ajr.179.2.1790385 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12130438 }} </ref> | *The [[ultrasound]] appearance can be non-specific and may not be reliable to differentiate between hyperplasia and [[carcinoma]].<ref name="pmid12130438">{{cite journal| author=Jorizzo JR, Chen MY, Martin D, Dyer RB, Weber TM| title=Spectrum of endometrial hyperplasia and its mimics on saline hysterosonography. | journal=AJR Am J Roentgenol | year= 2002 | volume= 179 | issue= 2 | pages= 385-9 | pmid=12130438 | doi=10.2214/ajr.179.2.1790385 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12130438 }} </ref> | ||
*The pelvic ultrasound shows a homogeneous increase in the endometrial thickness. However, endometrial hyperplasia may also cause asymmetric or focal thickening with surface irregularity which should raise a suspicion for | *The pelvic [[ultrasound]] shows a homogeneous increase in the endometrial thickness. However, endometrial hyperplasia may also cause asymmetric or focal thickening with surface irregularity which should raise a suspicion for [[malignancy]].<ref name=qw>Endometrial hyperplasia. Radiopedia. http://radiopaedia.org/articles/endometrial-hyperplasia-1 Accessed on March 10, 2016.</ref> | ||
*On pelvic ultrasound, endometrial hyperplasia is characterized by:<ref name=qw>Endometrial hyperplasia. Radiopedia. http://radiopaedia.org/articles/endometrial-hyperplasia-1 Accessed on March 10, 2016.</ref> | *On pelvic [[ultrasound]], endometrial hyperplasia is characterized by:<ref name=qw>Endometrial hyperplasia. Radiopedia. http://radiopaedia.org/articles/endometrial-hyperplasia-1 Accessed on March 10, 2016.</ref> | ||
'''Premenopausal''' | '''[[Premenopausal]]''' | ||
*An endometrial thickness of >15 mm is considered above normal during the secretory phase of menstrual cycle | *An endometrial thickness of >15 mm is considered above normal during the [[secretory phase]] of [[menstrual cycle]] | ||
'''Postmenopausal''' | '''[[Postmenopausal]]''' | ||
*An endometrial thickness of >5 mm is considered abnormal | *An endometrial thickness of >5 mm is considered abnormal | ||
===Tamoxifen associated endometrial changes=== | ===Tamoxifen associated endometrial changes=== | ||
*On pelvic ultrasound, tamoxifen induced endometrial hyperplasia is characterized by thickened, irregular, and cystic endometrium. | *On pelvic [[ultrasound]], [[tamoxifen]] induced endometrial hyperplasia is characterized by thickened, irregular, and cystic [[endometrium]]. | ||
*Changes tend to be subendometrial in location and may cause subendometrial | *Changes tend to be subendometrial in location and may cause subendometrial [[cyst]]s.<ref name=nb>Tamoxifen associated endometrial changes. Radiopedia. http://radiopaedia.org/articles/tamoxifen-associated-endometrial-changes Accessed on March 15, 2016.</ref> | ||
*The degree of endometrial thickening corresponds to the duration of tamoxifen therapy.<ref name=nb>Tamoxifen associated endometrial changes. Radiopedia. http://radiopaedia.org/articles/tamoxifen-associated-endometrial-changes Accessed on March 15, 2016.</ref> | *The degree of endometrial thickening corresponds to the duration of [[tamoxifen]] therapy.<ref name=nb>Tamoxifen associated endometrial changes. Radiopedia. http://radiopaedia.org/articles/tamoxifen-associated-endometrial-changes Accessed on March 15, 2016.</ref> | ||
==References== | ==References== |
Revision as of 12:58, 17 March 2016
Endometrial hyperplasia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Endometrial hyperplasia ultrasound On the Web |
American Roentgen Ray Society Images of Endometrial hyperplasia ultrasound |
Risk calculators and risk factors for Endometrial hyperplasia ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Soujanya Thummathati, MBBS [2]
Overview
Pelvic ultrasound on days 5 to 10 of menstrual cycle reduce the variability in endometrial thickness and may be helpful in the diagnosis of endometrial hyperplasia. On pelvic ultrasound, endometrial hyperplasia is characterized by a homogeneous increase in the endometrial thickness in the majority of patients. However, endometrial hyperplasia may also cause asymmetric or focal thickening with surface irregularity which should raise a suspicion for malignancy.[1]
Ultrasound
- Pelvic ultrasound on days 5 to 10 of menstrual cycle reduce the variability in endometrial thickness and may be helpful in the diagnosis of endometrial hyperplasia.
- The ultrasound appearance can be non-specific and may not be reliable to differentiate between hyperplasia and carcinoma.[2]
- The pelvic ultrasound shows a homogeneous increase in the endometrial thickness. However, endometrial hyperplasia may also cause asymmetric or focal thickening with surface irregularity which should raise a suspicion for malignancy.[1]
- On pelvic ultrasound, endometrial hyperplasia is characterized by:[1]
- An endometrial thickness of >15 mm is considered above normal during the secretory phase of menstrual cycle
- An endometrial thickness of >5 mm is considered abnormal
Tamoxifen associated endometrial changes
- On pelvic ultrasound, tamoxifen induced endometrial hyperplasia is characterized by thickened, irregular, and cystic endometrium.
- Changes tend to be subendometrial in location and may cause subendometrial cysts.[3]
- The degree of endometrial thickening corresponds to the duration of tamoxifen therapy.[3]
References
- ↑ 1.0 1.1 1.2 Endometrial hyperplasia. Radiopedia. http://radiopaedia.org/articles/endometrial-hyperplasia-1 Accessed on March 10, 2016.
- ↑ Jorizzo JR, Chen MY, Martin D, Dyer RB, Weber TM (2002). "Spectrum of endometrial hyperplasia and its mimics on saline hysterosonography". AJR Am J Roentgenol. 179 (2): 385–9. doi:10.2214/ajr.179.2.1790385. PMID 12130438.
- ↑ 3.0 3.1 Tamoxifen associated endometrial changes. Radiopedia. http://radiopaedia.org/articles/tamoxifen-associated-endometrial-changes Accessed on March 15, 2016.